Pharmagreen Biotech

Pharmagreen Biotech EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Pharmagreen Biotech (PHBI) as of Nov 4, 2026 is -60.78. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -50.47 — a change of 20.42% (lower).

EV/FCF

-60.78

YoY

20.42%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Pharmagreen Biotech is 2025 -60.78 . EV/FCF (Enterprise Value to Free Cash Flow) of Pharmagreen Biotech was 2024 -50.47 . It decreases by 20.42% lower compared to the previous year.

The Pharmagreen Biotech EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-0.88 USD
Jan 1, 2019
-2.09 USD
Jan 1, 2020
-2.90 USD
Jan 1, 2021
-6.34 USD
Jan 1, 2022
-3.26 USD
Jan 1, 2023
-19.41 USD
Jan 1, 2024
-50.47 USD
Jan 1, 2025
-60.78 USD
The Pharmagreen Biotech EV/FCF history
YEAREV/FCFYoY
-60.78+20.42%
-50.47+160.00%
-19.41+494.71%
-3.26-48.52%
-6.34+118.40%
-2.90+38.70%
-2.09+138.33%
-0.88-97.96%
-43.10—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pharmagreen Biotech Stock analysis

What does Pharmagreen Biotech do? Pharmagreen Biotech Inc is a Canadian company specializing in the production of cannabis plants. The company was founded in 2009. Initially, the company focused primarily on research in the field of plant biotechnology. It worked on developing plants with higher cold resistance for cultivation in colder regions. Research in breeding plants with higher nutritional value was also part of their focus. In 2017, the company recognized the incredible potential of the cannabis industry and decided to apply its expertise in this field. Pharmagreen Biotech Inc began large-scale production of cannabis plants, working closely with other industry leaders to optimize production and create the best possible conditions. Pharmagreen Biotech Inc places great importance on sustainability and environmental awareness. All production methods are designed with ecological sustainability in mind. The plants are grown in environmentally-friendly greenhouses and all waste is recycled and reused. The business model of Pharmagreen Biotech Inc is tailored to the needs of its customers. The company produces cannabis plants for the medical and recreational sectors. It offers various types of plants to meet the needs of customers, including plants for home cultivation to cater to the growing market for self-grown cannabis plants. Products offered by Pharmagreen Biotech Inc also include seeds, fertilizers, and specialized cultivation kits tailored to the needs of cannabis plants. The company works closely with laboratories and research institutions to maximize and optimize the quality and potency of its products. The company recently developed a new technology called "Speed Breeding," which allows for the rapid breeding of cannabis plants. This enables Pharmagreen Biotech Inc to serve an even larger portion of the market and provide faster availability of products for customers. Pharmagreen Biotech Inc is divided into various divisions, including medical cannabis production, recreational cannabis, plant products, and seed production. Each division is led by a specialized team focused on the needs and requirements of customers in that area. Overall, Pharmagreen Biotech Inc is an innovative and sustainable company focused on the needs of its customers. Its wide range of products and ongoing research and development make it an important player in the rapidly growing cannabis industry. Pharmagreen Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pharmagreen Biotech stock

EV/FCF (Enterprise Value to Free Cash Flow) of Pharmagreen Biotech is -60.78 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Pharmagreen Biotech changed from -50.47 to -60.78, representing a 20.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Pharmagreen Biotech since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Pharmagreen Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Pharmagreen Biotech

All Key Metrics — Pharmagreen Biotech